Dynamic Monitoring of Gene Changes and Its Prognostic Value in Lung Cancer Patients

Background Targeted therapy, represented by epidermal growth factor receptor-targeting tyrosine kinase inhibitors (EGFR-TKIs) , has significantly prolonged the survival time of patients with EGFR mutations with relatively mild adverse reactions, and become a prior choice for advanced non-small cell...

Descripció completa

Dades bibliogràfiques

Autor principal:	XUE Chongxiang, LU Xingyu, LIU Zhening, DONG Huijing, ZHENG Yumin, CUI Huijuan
Format:	Artigo
Idioma:	Chinês
Publicat:	Chinese General Practice Publishing House Co., Ltd 2023-12-01
Col·lecció:	Zhongguo quanke yixue
Matèries:	lung neoplasms|epidermal growth factor|epidermal growth factor receptor inhibitor|genetic testing|tumor progression|mutation rules|survival follow-up|prognosis
Accés en línia:	https://www.chinagp.net/fileup/1007-9572/PDF/20220833.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!